InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,230.00
(
-0.15%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
63,959.14
(
-0.20%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PG

Send PM Follow Ignore
Followers 105
Posts 871
Boards Moderated 0
Alias Born 03/27/2013

PG

Re: None

Tuesday, 07/09/2013 9:19:28 PM

Tuesday, July 09, 2013 9:19:28 PM

Post# of 158400
OK, here is the IND info for dummies (no offense, folks.), courtesy of the kind people at University of Kansas Medical.

http://www.kumc.edu/Documents/ri/cra/IND_101.pdf

Understand, as I said, that this treatment & BMSN do not qualify for "categorical exclusion" nor are candidates for clinical trial hold. It is simply that the FDA needed clarification on some things. And it really could be anything.

In the grand scheme, it really is no biggie that we have not heard anything yet.

Sometimes, you just have to walk away, let the dust settle and look at it all from a different perspective.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up